Month: June 2021

Blog

Monkey Tumor necrosis factor

Recombinant (active) mouse TNF alpha protein Biological activity Fully active compared to a standard. The ED50 determined by the dose-dependent killing/apoptosis of L-929 cells is 1.12 ng / ml corresponding to a specific activity of 8.93 x 105 IU / mg. Purity: = 95% SDS-PAGE. Purity by HPLC> = 95%. Endotoxin Level: <0.005 Eu / […]

Read More
Blog

PD 161570

Properties Related Categories Approved Therapeutics / Drug Candidates, Bioactive Small Molecules Alphabetical Index, Bioactive Small Molecules, Cell Biology, Cell Signaling, and Neuroscience, Quality level: 100 Assay: ≥98% (HPLC) Form: dust mfr. No:  Pfizer® Color: white to off-white Solubility DMSO :> 10 mg / mL Creator: Pfizer Description Packaging 5, 25 mg in a glass bottle […]

Read More
Blog

T-5224

Resume Background Sepsis is a potentially fatal syndrome mediated by an early [eg, tumor necrosis factor-alpha (TNF-α)] and late [high-mobility group box 1 (HMGB-1)] cytokine response to infection. Sepsis-induced acute kidney injury (ARI) is associated with high mortality. C-Fos / activator protein-1 (AP-1) controls the transactivation of pro-inflammatory cytokines through the binding of AP-1 in […]

Read More
Blog

AVE 0991

Description AVE 0991 is an orally active, non-peptide angiotensin (1-7) receptor agonist with an IC50 of 21 nM. IC50 and target IC50: 21 ± 35 nM (receptor Ang- (1-7)) In vitro AVE 0991 is a non-peptide compound that evokes Ang- (1-7) -like effects on the endothelium. AVE 0991 and unlabeled Ang- (1-7) compete for high-affinity […]

Read More
Blog

Synthetic 6XHis peptide

Product name: 6x Your tag, peptide Full Product Name: 6x Peptide from your tag For research use only: It should not be used in diagnostic procedures. Sequence: HHHHHH Host: Synthetic Purity / Purification: 0.95 Preparation and storage Store at -20 degrees C or -80 degrees C. Avoid repeated freeze/thaw cycles. Other notes Occasionally, small volumes […]

Read More